Home › Funds › Strive Asset Management, LLC › ABT

Strive Asset Management, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Strive Asset Management, LLC reported holding 3,063 shares of ABT (ABBOTT LABORATORIES) in its Q3 2025 13F filing — a position valued at US$410K, representing 0.22% of its reported portfolio and ranking #46 among its reported holdings. Strive Asset Management, LLC has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2024.

Latest position (Q3 2025)3.06K sh
Reported value held$410.26K
Portfolio Weight0.22%
First reportedQ4 2024
Last changeReduce
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Strive Asset Management, LLC's ABT position evolved

Strive Asset Management, LLC first disclosed a stake in ABT in Q4 2024 at 6,286 shares (US$711K). The position peaked in Q1 2025 at 5,741 shares, worth US$762K. Across 4 filings, Strive Asset Management, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2025) shows 3,063 shares valued at US$410K — a reduction of -409 shares quarter over quarter.. Notable position changes include a 40% trim in Q2 2025 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 6.29K $711.01K New
Q1 2025 5.74K $761.54K Reduce
Q2 2025 3.47K $472.23K Reduce
Q3 2025 3.06K $410.26K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Strive Asset Management, LLC held ABT?

Strive Asset Management, LLC has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2024.

What is Strive Asset Management, LLC's current position in ABT?

As of Q3 2025, Strive Asset Management, LLC holds 3.06K shares of ABT (ABBOTT LABORATORIES), valued at $410.26K, representing 0.22% of its reported portfolio and ranking #46.

Has Strive Asset Management, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2025), Strive Asset Management, LLC reduced its position in ABT. The position peaked in Q1 2025 at 5.74K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.